查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1765149

全球灌注系统市场

Perfusion Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球灌注系统市场规模将达到 16 亿美元

全球灌注系统市场规模预计在2024年为12亿美元，到2030年将达到16亿美元，在2024-2030年的分析期间内，复合年增长率为4.4%。心肺灌注系统是本报告分析的细分市场之一，预计其复合年增长率为3.4%，到分析期结束时规模将达到6.71亿美元。细胞灌注系统细分市场在分析期间内的复合年增长率预计为4.1%。

美国市场规模估计为 3.36 亿美元，中国市场预计复合年增长率为 4.1%

美国灌注系统市场规模预计2024年达到3.36亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到2.549亿美元，在2024-2030年的分析期间内，复合年增长率为4.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为4.0%和3.6%。在欧洲，预计德国市场的复合年增长率为4.5%。

全球灌注系统市场－主要趋势与驱动因素摘要

灌注系统将如何彻底改变医疗程序？

灌注系统在现代医疗程序中发挥着至关重要的作用，它在手术和其他关键医疗干预期间有效地向组织和器官输送氧气和必需营养素。这些系统在心肺体外迴圈手术、器官移植和各种加护治疗中至关重要。例如，在开胸心臟外科手术期间，灌注系统暂时接管心臟和肺部的功能，维持血液循环和氧气供应。此功能对于复杂外科手术的成功至关重要，并显着改善了患者的预后。此外，在器官移植中，灌注系统用于保存体外器官，延长移植时间并提高捐赠器官的存活率。灌注系统的精确性和可靠性彻底改变了外科手术和重症加护领域，使得更复杂和挽救生命的手术能够安全地进行。

哪些技术创新正在塑造灌注系统？

技术创新是灌注系统进步的前沿，提高了系统的效率、安全性和功能性。一个显着的发展是先进监测和控制技术的集成，可以即时评估和调整灌注参数。这确保了最佳灌注条件并降低了併发症的风险。另一项关键创新是在灌注设备的构造中使用生物相容性材料和涂层，最大限度地降低了副作用的风险并提高了患者的安全性。此外，可携式微创灌注系统的出现已将其应用范围从手术室扩展到了野战医院和急救环境。软体和数据分析的进步也使得更精确的控制和监测成为可能，从而改善了手术和非手术程序的结果。这些技术进步使灌注系统更加通用和有效，满足了医疗保健专业人员不断变化的需求。

灌注系统在不同的医学学科中是如何应用的？

灌注系统广泛应用于各个医学学科，每个学科都有其独特的功能来改善病患照护。在循环系统医学中，灌注系统对于冠状动脉绕道手术和瓣膜置换术至关重要。在移植医学中，灌注系统维持并提高肾臟、肝臟和心臟等器官的活力，从而确保移植成功并减少等待时间。在肿瘤学中，灌注系统用于隔离肢体灌注技术，将高剂量的化疗输送到特定部位并最大限度地减少全身副作用。此外，在重症加护中，体外膜氧气疗法(ECMO) 是灌注技术的一种救生应用，为患有严重心臟和肺部疾病的患者提供延长的心臟和呼吸支持。灌注系统的多功能性和有效性在改善这些不同应用的治疗和患者预后方面发挥关键作用。

哪些因素推动了灌注系统市场的成长？

灌注系统市场的成长受到多种因素的推动。主要驱动因素之一是心血管疾病的日益增加以及对心血管手术和介入的需求不断增加。全球人口老化也促进了市场扩张，因为老年人更有可能需要依赖灌注系统的手术。更复杂的可携式灌注设备等技术进步透过扩大应用范围和改善患者预后，进一步推动了市场成长。此外，对器官移植的日益重视和器官保存技术的不断改进正在推动对灌注系统的需求。灌注系统在肿瘤学和再生医学等新兴领域的日益广泛使用也是一个主要的成长动力。随着医疗保健提供者寻求改善治疗结果和患者照护，对先进灌注系统的需求正在上升，预计这将在未来几年推动强劲的市场成长。

部分

应用（心肺灌注系统、细胞灌注系统、离体器官灌注系统）

受访公司范例

  • ALA Scientific Instruments, Inc.
  • Getinge AB
  • Harvard Bioscience, Inc.
  • Lifeline Scientific, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • Merck KgaA
  • Nipro Corporation
  • Repligen Corporation
  • Spectrum Laboratories, Inc.
  • Terumo Corporation
  • Xenios AG
  • XVIVO Perfusion AB

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP13918

Global Perfusion Systems Market to Reach US$1.6 Billion by 2030

The global market for Perfusion Systems estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Cardiopulmonary Perfusion Systems, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$671.0 Million by the end of the analysis period. Growth in the Cell Perfusion Systems segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$336.0 Million While China is Forecast to Grow at 4.1% CAGR

The Perfusion Systems market in the U.S. is estimated at US$336.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$254.9 Million by the year 2030 trailing a CAGR of 4.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Perfusion Systems Market - Key Trends and Drivers Summarized

How Do Perfusion Systems Revolutionize Medical Procedures?

Perfusion systems play a crucial role in modern medical procedures by ensuring the effective delivery of oxygen and essential nutrients to tissues and organs during surgeries and other critical medical interventions. These systems are indispensable in cardiopulmonary bypass surgeries, organ transplantation, and various forms of intensive care. During open-heart surgery, for example, perfusion systems temporarily take over the function of the heart and lungs, maintaining blood circulation and oxygenation. This capability is vital for the success of complex surgical procedures and has significantly improved patient outcomes. Moreover, in organ transplantation, perfusion systems are used to preserve organs outside the body, extending the time available for transplantation and improving the viability of donor organs. The precision and reliability of perfusion systems have revolutionized the field of surgery and critical care, enabling more complex and life-saving procedures to be performed safely.

What Technological Innovations Are Shaping Perfusion Systems?

Technological innovations are at the forefront of advancements in perfusion systems, enhancing their efficiency, safety, and functionality. One notable development is the integration of advanced monitoring and control technologies, which allow for real-time assessment and adjustment of perfusion parameters. This ensures optimal perfusion conditions and reduces the risk of complications. Another significant innovation is the use of biocompatible materials and coatings in the construction of perfusion devices, which minimizes the risk of adverse reactions and enhances patient safety. Additionally, the advent of portable and minimally invasive perfusion systems has expanded their use beyond the operating room to include field hospitals and emergency settings. Advances in software and data analytics also enable more precise control and monitoring, improving outcomes in both surgical and non-surgical applications. These technological strides are making perfusion systems more versatile and effective, meeting the evolving needs of healthcare providers.

How Are Perfusion Systems Applied in Various Medical Fields?

Perfusion systems are applied across a broad spectrum of medical fields, each leveraging their capabilities to enhance patient care. In cardiovascular medicine, these systems are essential for procedures like coronary artery bypass grafting and valve replacement surgeries. In transplantation medicine, perfusion systems preserve and enhance the viability of organs such as kidneys, livers, and hearts, facilitating successful transplants and reducing waiting times. In oncology, perfusion systems are used in isolated limb perfusion techniques to deliver high doses of chemotherapy to specific areas, minimizing systemic side effects. Additionally, in critical care, extracorporeal membrane oxygenation (ECMO) is a life-saving application of perfusion technology, providing prolonged cardiac and respiratory support to patients with severe heart and lung conditions. The versatility and effectiveness of perfusion systems in these varied applications underscore their vital role in advancing medical treatment and patient outcomes.

What Factors Are Driving the Growth in the Perfusion Systems Market?

The growth in the perfusion systems market is driven by several factors. One of the primary drivers is the increasing prevalence of cardiovascular diseases and the rising demand for cardiac surgeries and interventions. The aging global population is also contributing to the market expansion, as older individuals are more likely to require surgeries that depend on perfusion systems. Technological advancements, such as the development of more sophisticated and portable perfusion devices, are further propelling market growth by expanding the range of applications and improving patient outcomes. Additionally, the growing emphasis on organ transplantation and the continuous improvement in organ preservation techniques are boosting the demand for perfusion systems. The expanding use of perfusion systems in emerging fields such as oncology and regenerative medicine is also a significant growth driver. As healthcare providers seek to enhance treatment efficacy and patient care, the demand for advanced perfusion systems is set to increase, ensuring robust market growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Perfusion Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Cardiopulmonary Perfusion Systems, Cell Perfusion Systems, EX Vivo Organ Perfusion System)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • ALA Scientific Instruments, Inc.
  • Getinge AB
  • Harvard Bioscience, Inc.
  • Lifeline Scientific, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • Merck KgaA
  • Nipro Corporation
  • Repligen Corporation
  • Spectrum Laboratories, Inc.
  • Terumo Corporation
  • Xenios AG
  • XVIVO Perfusion AB

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Perfusion Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Organ Preservation Technologies Propel Growth in Perfusion Systems Market
    • Increasing Demand for Minimally Invasive Surgical Procedures Strengthens Business Case for Perfusion Systems
    • Technological Innovations in Perfusion Pumps Accelerate Market Adoption
    • Rising Prevalence of Cardiovascular Diseases Spurs Demand for Perfusion Systems
    • Expansion of Organ Transplantation Procedures Generates Market Opportunities
    • Growing Investments in Healthcare Infrastructure Sustain Market Growth
    • Adoption of Portable and Compact Perfusion Systems Expands Addressable Market
    • Increasing Focus on Patient Safety and Outcome Improves Demand for Advanced Perfusion Systems
    • Regulatory Approvals and Compliance Requirements Propel Market Growth
    • Development of Smart Perfusion Systems with Real-Time Monitoring Throws Spotlight on Technological Advancements
    • Rising Geriatric Population Drives Demand for Cardiac Perfusion Systems
    • Increasing Number of Critical Care Units Drives Adoption of Perfusion Systems
    • Strategic Collaborations and Partnerships in Healthcare Sector Strengthen Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cardiopulmonary Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cardiopulmonary Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Cardiopulmonary Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cell Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cell Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Cell Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Perfusion Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for EX Vivo Organ Perfusion System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for EX Vivo Organ Perfusion System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for EX Vivo Organ Perfusion System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • JAPAN
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • CHINA
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • EUROPE
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Perfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Perfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • FRANCE
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • GERMANY
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Rest of Europe Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Rest of Europe 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Asia-Pacific Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Asia-Pacific 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of World Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of World 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030

IV. COMPETITION